Chlovek Life Sciences Private Limited
About Chlovek Life Sciences Private Limited
Data last updated:
Chlovek Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the services rendered by liaison offices segment of the business services sector. It was incorporated on 05 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74995DL2018PTC334907. Its GSTIN is 09AAHCC6125C1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sourav Arora and Deepali Grover.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at New T Block H.N.40 Near Bindapur Matilya Road Om Vihar Uttam Nagar, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2024, the company reported a revenue of ₹47.67 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹2,760 (net margin 0.1%) and EBITDA of ₹2,760 (EBITDA margin 0.1%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 30% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNew T Block H.N.40 Near Bindapur Matilya Road Om Vihar Uttam Nagar, New Delhi, Delhi, India – 110059
- IndustryBusiness Services, Services Rendered By Liaison Offices, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Chlovek Life Sciences Private Limited
FY 2025 filings availableChlovek Life Sciences Private Limited reported revenue of ₹47.67 Lakh (up 32% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 32% growth in the latest year. EBITDA rose 360% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹2,760 | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹2,760 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.1% | |
| Net Profit Margin | 0.1% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2019-20 to FY 2022-23, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Chlovek Life Sciences are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors of Chlovek Life Sciences Private Limited
Chlovek Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sourav Arora | Director | 05 Jun 2018 | 8 Years 4 Months | Current |
| Deepali Grover | Director | 27 Sep 2022 | 4 Years 0 Months | Current |
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Chlovek Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Chlovek Life Sciences.
: available in the company report
Recent Activity
Chlovek Life Sciences Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Bharat Agarwal ceased to be Director on 27 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Chlovek Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCC6125C1ZX | Uttar Pradesh | Active | 18 Jul 2018 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Chlovek Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in services rendered by liaison offices, within the business services industry. It was incorporated on 05 June 2018 (8+ years old) and is registered under CIN U74995DL2018PTC334907.
Chlovek Life Sciences has 2 current directors:
- Sourav Arora - Director
- Deepali Grover - Director
The latest financial statements of Chlovek Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Chlovek Life Sciences is 09AAHCC6125C1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Chlovek Life Sciences is U74995DL2018PTC334907. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chlovek Life Sciences was incorporated on 05 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Bharat Agarwal ceased to be Director on 27 Sep 2022. Deepali Grover was appointed as Director on 27 Sep 2022. Sourav Arora was appointed as Director on 05 Jun 2018.
The registered office of Chlovek Life Sciences is at New T Block H.N.40 Near Bindapur Matilya Road Om Vihar Uttam Nagar, New Delhi, Delhi, India – 110059.
Chlovek Life Sciences operates in the business services industry, in the services rendered by liaison offices segment.
Chlovek Life Sciences can be reached at its registered office: New T Block H.N.40 Near Bindapur Matilya Road Om Vihar Uttam Nagar, New Delhi, Delhi, India – 110059.